Healthcare • Diagnostics & Research
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if NTRA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
131 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 12 days ago
Red flags: 10
849 filers reported a long position in NTRA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| JPMORGAN CHASE & CO | $3.5B | 12.9M | -3.9% |
| BlackRock, Inc. | $3B | 10.9M | +2.2% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $2.4B | 9M | -26% |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.7B | 6.2M | +3.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.6B | 5.8M | +2.4% |
| FMR LLC | $1.5B | 5.5M | +113.4% |
| WELLINGTON MANAGEMENT GROUP LLP | $1.1B | 4M | -15.3% |
| STATE STREET CORP | $992.3M | 3.7M | +7% |
| Duquesne Family Office LLC | $864.9M | 3.2M | +4% |
| GEODE CAPITAL MANAGEMENT, LLC | $744.6M | 2.8M | -0.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.